Free Trial

Virpax Pharmaceuticals (VRPX) SEC Filings & 10K Form

Virpax Pharmaceuticals logo
$0.21 -0.02 (-8.70%)
As of 04/16/2025 03:34 PM Eastern

Recent Virpax Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/03/2025
10:00 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2025
5:10 AM
Virpax Pharmaceuticals (Filer)
Form S-1/A
03/21/2025
4:20 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2025
3:30 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2025
4:00 PM
Virpax Pharmaceuticals (Filer)
Form 424B4
01/27/2025
11:15 PM
Virpax Pharmaceuticals (Filer)
Form EFFECT
01/15/2025
3:31 PM
Virpax Pharmaceuticals (Filer)
Form S-1/A
01/08/2025
3:11 PM
Panis Jaydriane (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/07/2025
3:30 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/30/2024
3:47 PM
Virpax Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
12/30/2024
3:05 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
4:00 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2024
4:15 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2024
4:29 PM
Virpax Pharmaceuticals (Filer)
Form DEF 14A
11/29/2024
5:39 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2024
4:01 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2024
3:31 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2024
5:06 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
4:20 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
11:15 PM
Virpax Pharmaceuticals (Filer)
Form EFFECT
11/07/2024
4:01 PM
Virpax Pharmaceuticals (Filer)
Form S-1/A
10/28/2024
3:08 PM
Virpax Pharmaceuticals (Filer)
Form S-1/A
10/18/2024
4:28 PM
Virpax Pharmaceuticals (Filer)
Form S-1/A
10/10/2024
4:07 PM
Virpax Pharmaceuticals (Filer)
Form 10-K/A
10/10/2024
4:08 PM
Virpax Pharmaceuticals (Filer)
Form 10-K/A
10/09/2024
4:00 PM
Virpax Pharmaceuticals (Filer)
Form 8-K/A
10/04/2024
3:30 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2024
3:30 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2024
3:12 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
8:05 AM
Virpax Pharmaceuticals (Filer)
Form S-1/A
08/13/2024
6:35 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2024
4:26 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2024
3:30 PM
Virpax Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
07/26/2024
3:31 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2024
6:45 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2024
5:40 PM
Su Judy (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/15/2024
7:00 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2024
3:09 PM
Field Katharyn (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/10/2024
3:10 PM
Field Katharyn (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2024
11:48 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2024
3:00 PM
Dhaliwal Jatinder (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
The Trump Dump is starting; Get out of stocks now? (Ad)

The first 365 days of the Trump presidency… Will be the best time to get rich in American history.

If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a
07/09/2024
3:01 PM
Herman Gary L (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/09/2024
3:02 PM
Dhaliwal Jatinder (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2024
3:03 PM
Herman Gary L (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
3:32 PM
Virpax Pharmaceuticals (Filer)
Form DEFA14A
07/08/2024
6:30 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2024
4:09 PM
Virpax Pharmaceuticals (Filer)
Form DEF 14A
06/12/2024
4:11 PM
Virpax Pharmaceuticals (Filer)
Form ARS
05/14/2024
11:15 PM
Virpax Pharmaceuticals (Filer)
Form EFFECT
05/13/2024
4:30 PM
Virpax Pharmaceuticals (Filer)
Form S-1/A
05/13/2024
3:02 PM
Virpax Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2024
8:54 PM
Virpax Pharmaceuticals (Filer)
Form S-1/A
04/30/2024
6:35 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
4:15 PM
Virpax Pharmaceuticals (Filer)
Form S-1/A
04/18/2024
3:17 PM
Virpax Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:VRPX) was last updated on 4/17/2025 by MarketBeat.com Staff
From Our Partners